Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 072
mi
from
Little Rock, AR
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 072
mi
from
Little Rock, AR
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 015
mi
from
Springdale, AR
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 015
mi
from
Springdale, AR
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 080
mi
from
Carson, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 080
mi
from
Carson, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 012
mi
from
Cerritos, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 012
mi
from
Cerritos, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 01
mi
from
Escondido, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 01
mi
from
Escondido, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site #021
mi
from
Garden Grove, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site #021
mi
from
Garden Grove, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 004
mi
from
Long Beach, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 004
mi
from
Long Beach, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site
mi
from
Oceanside, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Oceanside, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 42
mi
from
Paramount, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 42
mi
from
Paramount, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 005
mi
from
Riverside, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 005
mi
from
Riverside, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 016
mi
from
San Diego, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 016
mi
from
San Diego, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 073
mi
from
Santa Ana, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 073
mi
from
Santa Ana, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 065
mi
from
Highlands Ranch, CO
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 065
mi
from
Highlands Ranch, CO
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 016
mi
from
New Britain, CT
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 016
mi
from
New Britain, CT
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 007
mi
from
Washington,
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 007
mi
from
Washington,
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site
mi
from
Kissimmee, FL
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Kissimmee, FL
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site #005
mi
from
North Miami, FL
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site #005
mi
from
North Miami, FL
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 013
mi
from
Honolulu, HI
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 013
mi
from
Honolulu, HI
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 009
mi
from
Chicago, IL
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 009
mi
from
Chicago, IL
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 011
mi
from
Hoffman Estates, IL
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 011
mi
from
Hoffman Estates, IL
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 006
mi
from
Rockville, MD
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 006
mi
from
Rockville, MD
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 001
mi
from
Flowood, MS
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 001
mi
from
Flowood, MS
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 022
mi
from
Creve Coeur, MO
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 022
mi
from
Creve Coeur, MO
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 076
mi
from
St. Charles, MO
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 076
mi
from
St. Charles, MO
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 025
mi
from
St. Louis, MO
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 025
mi
from
St. Louis, MO
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 012
mi
from
Las Vegas, NV
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 012
mi
from
Las Vegas, NV
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 002
mi
from
Willingboro, NJ
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 002
mi
from
Willingboro, NJ
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Neuro-Pain Medical Center
mi
from
Fresno, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Neuro-Pain Medical Center
mi
from
Fresno, CA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 005
mi
from
Cincinnati, OH
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 005
mi
from
Cincinnati, OH
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 019
mi
from
Willoughby, OH
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 019
mi
from
Willoughby, OH
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 075
mi
from
Tusla, OK
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 075
mi
from
Tusla, OK
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 077
mi
from
Philadelphia, PA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 077
mi
from
Philadelphia, PA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
CRI Worldwide
mi
from
Mt Laurel, NJ
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
CRI Worldwide
mi
from
Mt Laurel, NJ
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site
mi
from
Memphis, TN
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Memphis, TN
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 13
mi
from
Nashville, TN
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 13
mi
from
Nashville, TN
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 074
mi
from
Austin, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 074
mi
from
Austin, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 018
mi
from
DeSoto, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 018
mi
from
DeSoto, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site
mi
from
Houston, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Houston, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 51
mi
from
Houston, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 51
mi
from
Houston, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 004
mi
from
Irving, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 004
mi
from
Irving, TX
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site
mi
from
Bellevue, WA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Bellevue, WA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Forest Investigative Site 014
mi
from
Bothell, WA
Long-term Study of Cariprazine in Patients With Schizophrenia
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 014
mi
from
Bothell, WA
An Open Trial of Cysteamine Treatment in Schizophrenia
An Open Trial of Cysteamine Treatment in Schizophrenia
Status: Archived
Med College of Georgia
mi
from
Augusta, GA
An Open Trial of Cysteamine Treatment in Schizophrenia
An Open Trial of Cysteamine Treatment in Schizophrenia
Status: Archived
Updated: 1/1/1970
Med College of Georgia
mi
from
Augusta, GA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
K & S Professional Research Services
mi
from
Little Rock, AR
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Updated: 1/1/1970
K & S Professional Research Services
mi
from
Little Rock, AR
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Synergy Clinical Research
mi
from
Escondido, CA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Updated: 1/1/1970
Synergy Clinical Research
mi
from
Escondido, CA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Updated: 1/1/1970
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Pacific Research Partners, LLC
mi
from
Oakland, CA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Updated: 1/1/1970
Pacific Research Partners, LLC
mi
from
Oakland, CA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
California Clinical Trials
mi
from
Glendale, CA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Updated: 1/1/1970
California Clinical Trials
mi
from
Glendale, CA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Pasadena Research Institute
mi
from
Pasadena, CA
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Archived
Updated: 1/1/1970
Pasadena Research Institute
mi
from
Pasadena, CA